Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mulder

Showing results (271-280 of 429) with videos related to

Pageof 43
Sort By:
International Journal of Cancer|November 11, 1991
Ethnic differences in the anatomical location of colorectal adenomatous polypsG J Offerhaus, F M Giardiello, K W Tersmette, et al.
Pharmacy World & Science : PWS|November 24, 1995
Study on didanosine concentrations in cerebrospinal fluid. Implications for the treatment and prevention of AIDS dementia complexD M Burger, C L Kraayeveld, P L Meenhorst, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 15, 1995
Soluble tumor necrosis factor receptors as surrogate markers for the assessment of zidovudine treatment in asymptomatic HIV-1 infectionM H Godfried, T van der Poll, J W Mulder, et al.
Clinical Pharmacokinetics|February 27, 2003
Drug interactions between antiretroviral drugs and comedicated agentsMonique M R de Maat, G Corine Ekhart, Alwin D R Huitema, et al.
Therapeutic Drug Monitoring|May 22, 2001
Saliva as an alternative body fluid for therapeutic drug monitoring of the nonnucleoside reverse transcription inhibitor nevirapineR P van Heeswijk, A I Veldkamp, J W Mulder, et al.
AIDS (London, England)|July 14, 2000
Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot studyR P van Heeswijk, A I Veldkamp, J W Mulder, et al.
Cancer Research|May 3, 2006
Menin links estrogen receptor activation to histone H3K4 trimethylationKoen M A Dreijerink, Klaas W Mulder, G Sebastiaan Winkler, et al.
International Journal of STD & AIDS|September 1, 1994
Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan populationH U Wagner, E Van Dyck, E Roggen, et al.
The Journal of Infectious Diseases|January 1, 1992
Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjectsC A Boucher, E O'Sullivan, J W Mulder, et al.
Cancer Chemotherapy and Pharmacology|May 13, 1999
Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma--drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: a case report studyV R Nannan Panday, R M Hoetelmans, R P van Heeswijk, et al.
Pageof 43

Showing results (271-280 of 429) with videos related to

Sort By:
Pageof 43
International Journal of Cancer|November 11, 1991
Ethnic differences in the anatomical location of colorectal adenomatous polypsG J Offerhaus, F M Giardiello, K W Tersmette, et al.
Pharmacy World & Science : PWS|November 24, 1995
Study on didanosine concentrations in cerebrospinal fluid. Implications for the treatment and prevention of AIDS dementia complexD M Burger, C L Kraayeveld, P L Meenhorst, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 15, 1995
Soluble tumor necrosis factor receptors as surrogate markers for the assessment of zidovudine treatment in asymptomatic HIV-1 infectionM H Godfried, T van der Poll, J W Mulder, et al.
Clinical Pharmacokinetics|February 27, 2003
Drug interactions between antiretroviral drugs and comedicated agentsMonique M R de Maat, G Corine Ekhart, Alwin D R Huitema, et al.
Therapeutic Drug Monitoring|May 22, 2001
Saliva as an alternative body fluid for therapeutic drug monitoring of the nonnucleoside reverse transcription inhibitor nevirapineR P van Heeswijk, A I Veldkamp, J W Mulder, et al.
AIDS (London, England)|July 14, 2000
Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot studyR P van Heeswijk, A I Veldkamp, J W Mulder, et al.
Cancer Research|May 3, 2006
Menin links estrogen receptor activation to histone H3K4 trimethylationKoen M A Dreijerink, Klaas W Mulder, G Sebastiaan Winkler, et al.
International Journal of STD & AIDS|September 1, 1994
Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan populationH U Wagner, E Van Dyck, E Roggen, et al.
The Journal of Infectious Diseases|January 1, 1992
Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjectsC A Boucher, E O'Sullivan, J W Mulder, et al.
Cancer Chemotherapy and Pharmacology|May 13, 1999
Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma--drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: a case report studyV R Nannan Panday, R M Hoetelmans, R P van Heeswijk, et al.
Pageof 43